Biotech

Benzinga's 'Stock Whisper' Index: 5 Stocks Investors Secretly Monitor But Don't Talk About Yet
Evaxion Biotech Partners With Merck To Expand Vaccine Development
'Biggest Invention Since Lateral Flow': Gemina Labs CEO Touts Company's Transformative Diagnostics Deal
Evaxion Biotech Partners With Merck To Expand Vaccine Development
'Biggest Invention Since Lateral Flow': Gemina Labs CEO Touts Company's Transformative Diagnostics Deal
Health Care, Biotech Leaders To Unveil Cutting-Edge Innovations
This Biotech Stock Is Poised For 80% Upside With Breakthrough In Obesity Drug Market, Says JPMorgan

Biotech Recent News

These Biotech Stocks Could Double Your Money, According To Analysts
Elon Musk Questioned By Ethics Group Over Painful Deaths Of Monkeys Linked To Neuralink
Elon Musk is facing another round of allegations from an ethics group questioning him on the death of monkeys at biotech startup Neuralink.
EXCLUSIVE: Kidney Care Revolution? How Swedish Biopharma Calliditas Aims To Tackle A Rare Disease With 'Unique, But Pretty Simple' Drug
Calliditas, a rare disease company focused on kidney ailments, is optimistic of its lead drug taking off in a big way.
The Secret Behind Why Your Coffee and CBD Might Not Be Working
J&J Investors Will Soon Be Able To Exchange Shares For Kenvue Stocks
5 Biotech Stocks That Could Soar Thanks To These Disruptive Healthcare Technologies
The Companies That Led 2017's Biotech Rally
10 Biotech Stocks Moving From ASH 2017
It's A Bad Day For Biotechs
Pro: Biotech Is The Hottest ETF Of 2017 With Plenty Of Upside Ahead
A Sign Of Things To Come? Traders Are Betting On More Biotech Mergers
Small Biotechs Could Hurt From Scarcity Of Cancer Trial Participants
FDA's 60-Day Extension For Medical Device Defects Not Likely Obstructive To Public Health
Following Extended Consolidation Period, Biotech ETF's Next Breakout Could Be Big
Exclusive: CBMG CEO Talks Stem-Cell Therapies, Cancer Treatments, Financials & The Chinese Market
Viridian's President On Cannabis-Related Opportunities: AgTech And BioTech Offer Value To Investors
Biotech Stocks Convalescing After Wednesday's Trump-Inspired Biotech Selloff
Assessing The Legitimacy Of The Biotech ETF Bounce
4 Election-Proof Stocks: Biotech And Software Take The Lead
Exclusive: SunTrust Managing Director Discusses Bluebird Bio, A Leader In Gene Therapy
The Next Sector Rotation Will Be To Biotechs
Valeant Gets Closer To Left's $50 Target After New Accounting Fears
This Week Is Paramount For Biotech Stocks

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga

© 2024 Benzinga | All Rights Reserved